Winslow Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,330
Closed -$206K 81
2026
Q1
$206K Buy
+7,330
New +$195K 0.04% 77
2025
Q1
Sell
-7,981
Closed -$212K 77
2024
Q4
$212K Sell
7,981
-216
-3% -$5.86K 0.04% 74
2024
Q3
$237K Sell
8,197
-981
-11% -$28.6K 0.04% 71
2024
Q2
$257K Sell
9,178
-1,407
-13% -$38.7K 0.05% 67
2024
Q1
$294K Sell
10,585
-500
-5% -$13.9K 0.06% 66
2023
Q4
$319K Sell
11,085
-1,820
-14% -$55K 0.06% 65
2023
Q3
$428K Sell
12,905
-30
-0.2% -$1.06K 0.1% 57
2023
Q2
$474K Hold
12,935
0.1% 56
2023
Q1
$528K Sell
12,935
-83
-0.6% -$3.58K 0.12% 55
2022
Q4
$667K Sell
13,018
-1,103
-8% -$52.9K 0.16% 55
2022
Q3
$618K Sell
14,121
-1
-0% -$49 0.16% 56
2022
Q2
$740K Buy
14,122
+250
+2% +$12.7K 0.18% 53
2022
Q1
$718K Sell
13,872
-250
-2% -$13K 0.14% 60
2021
Q4
$834K Hold
14,122
0.15% 59
2021
Q3
$607K Hold
14,122
0.12% 63
2021
Q2
$553K Hold
14,122
0.1% 64
2021
Q1
$512K Hold
14,122
0.1% 61
2020
Q4
$520K Sell
14,122
-763
-5% -$28K 0.11% 62
2020
Q3
$518K Buy
14,885
+21
+0.1% +$736 0.13% 60
2020
Q2
$461K Hold
14,864
0.12% 59
2020
Q1
$460K Hold
14,864
0.15% 60
2019
Q4
$553K Hold
14,864
0.13% 66
2019
Q3
$507K Hold
14,864
0.13% 66
2019
Q2
$611K Hold
14,864
0.14% 66
2019
Q1
$599K Hold
14,864
0.13% 65
2018
Q4
$616K Buy
14,864
+2,361
+19% +$98K 0.14% 68
2018
Q3
$523K Sell
12,503
-7,640
-38% -$294K 0.1% 71
2018
Q2
$693K Hold
20,143
0.13% 67
2018
Q1
$678K Hold
20,143
0.13% 66
2017
Q4
$692K Hold
20,143
0.13% 66
2017
Q3
$682K Hold
20,143
0.13% 67
2017
Q2
$642K Sell
20,143
-1,344
-6% -$42.4K 0.13% 66
2017
Q1
$697K Sell
21,487
-29
-0.1% -$914 0.14% 66
2016
Q4
$663K Hold
21,516
0.14% 67
2016
Q3
$691K Hold
21,516
0.15% 67
2016
Q2
$719K Sell
21,516
-157
-0.7% -$5.01K 0.16% 67
2016
Q1
$609K Sell
21,673
-106
-0.5% -$3.03K 0.14% 66
2015
Q4
$667K Sell
21,779
-1,001
-4% -$31.5K 0.13% 67
2015
Q3
$679K Sell
22,780
-264
-1% -$8.46K 0.13% 66
2015
Q2
$733K Hold
23,044
0.13% 66
2015
Q1
$761K Hold
23,044
0.13% 64
2014
Q4
$681K Hold
23,044
0.11% 67
2014
Q3
$646K Buy
23,044
+37
+0.2% +$1.04K 0.11% 65
2014
Q2
$648K Hold
23,007
0.11% 65
2014
Q1
$701K Buy
23,007
+232
+1% +$6.92K 0.12% 63
2013
Q4
$662K Hold
22,775
0.12% 61
2013
Q3
$621K Hold
22,775
0.12% 62
2013
Q2
$605K Buy
+22,775
New +$629K 0.12% 61

Other funds holding PFE

Winslow Asset Management's PFE Position: Q2 2026 in Review

Winslow Asset Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,330 shares — an estimated $206K sold.

Winslow Asset Management first reported a position in PFE in Q2 2013 and held it in 48 quarters. The position peaked at $834K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Winslow Asset Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Winslow Asset Management sold 7,330 Pfizer shares in Q2 2026, an estimated $206K.
  • Winslow Asset Management first reported a position in Pfizer in Q2 2013 and held it in 48 quarters.
  • Winslow Asset Management's Pfizer position peaked at $834K in Q4 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Winslow Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.